- Report
- February 2026
- 184 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- January 2024
- 216 Pages
United States
From €3343EUR$3,750USD£2,888GBP
- Report
- March 2022
- 324 Pages
Global
From €8470EUR$9,500USD£7,316GBP
- Report
- August 2024
- 223 Pages
China
From €3566EUR$4,000USD£3,080GBP
- Report
- November 2025
- 85 Pages
Global
From €3500EUR$4,205USD£3,129GBP
- Report
- August 2024
- 104 Pages
China
From €1605EUR$1,800USD£1,386GBP
- Report
- November 2021
- 600 Pages
Global
From €3566EUR$4,000USD£3,080GBP
Metamizole, also known as dipyrone, is an analgesic drug used to treat mild to moderate pain. It is a non-opioid analgesic, meaning it does not have the same addictive potential as opioids. Metamizole is commonly used to treat headaches, muscle pain, and menstrual cramps. It is also used to reduce fever and inflammation. Metamizole is available in both oral and injectable forms.
Metamizole is a widely used analgesic in many countries, including Europe, Latin America, and Asia. It is often prescribed as an alternative to opioids, as it has fewer side effects and is less likely to be abused. Metamizole is also used in combination with other analgesics, such as paracetamol, to provide more effective pain relief.
Some of the companies in the Metamizole market include Novartis, Sanofi, Pfizer, Merck, and Bayer. Show Less Read more